IP protection for pharmaceuticals

It’s increasingly vital for pharmaceutical innovators to obtain and defend a robust IP portfolio that protects their research and development assets. Of similar importance is the monitoring of third-party rights that might disrupt the pharmaceutical value chain to clear the path where necessary.

Our expertise in pharmaceutical intellectual property

With many years’ experience of working in-house at major pharmaceutical companies, our team has considerable depth of expertise across many technical areas, ranging from small molecules to biologics.

Our focused, specialist group of IP attorneys represents and advises multinationals, universities and spin outs that conduct leading R&D to obtain, manage and defend their worldwide IP rights and to challenge third-party IP rights. We also advise on due diligence, freedom to operate, patentability, infringement and merger and acquisition matters.

With technical backgrounds and experience in the chemical and biological fields, we have an expertise in medicinal chemistry and pharmacology. We also have a wealth of experience in brand protection and have advised on a wide range of pharmaceutical matters relating to human and animal health.

With extensive experience in dealing with the many unique ethical and regulatory challenges, as well as navigating the constantly evolving legal landscape, we are ideally placed to protect your pharmaceutical technology via patents, supplementary protection certificates and trademarks.

Meet our extended team

Talk to us

Dr Simon Mitchell

Director, Patents

More on Pharmaceuticals

Keep up to date with the latest news and legal updates, or learn more about protecting your intellectual property

News & insights
Keep up to date with our latest News and Comment.
View our latest event programme. If you are going or want to go - let us know!
Register early for our latest online seminars, experience in-depth presentations on current IP topics - very popular with IP Professionals.